At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

Sponsor
ProofPilot (Industry)
Overall Status
Unknown status
CT.gov ID
NCT04393961
Collaborator
Radish Health (Other), Sanesco (Other)
600
1
4
4.8
125.1

Study Details

Study Description

Brief Summary

Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.

Condition or Disease Intervention/Treatment Phase
  • Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
600 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study will include four arms. The experiences across all 4 arms will be exactly the same. Each arm has a slightly different experience with COVID-19.This study will include four arms. The experiences across all 4 arms will be exactly the same. Each arm has a slightly different experience with COVID-19.
Masking:
None (Open Label)
Masking Description:
This is a device feasibility trial. There is no blinding or masking.
Primary Purpose:
Device Feasibility
Official Title:
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
Actual Study Start Date :
Apr 5, 2020
Anticipated Primary Completion Date :
Jul 29, 2020
Anticipated Study Completion Date :
Aug 29, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Past Positive COVID-19 confirmed

Invited participants who Radish Health has completed a positive COVID-19 test who have recovered from all symptoms for more than 14 days.

Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace. The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech. We chose the Precision Bio test for 4 reasons It is available as a single use test kit in one sealed unit. It's a rapid test, with results available in 10 minutes. It has clear and easy to read instructions already included It has one of the lowest false positive rates of known tests at the moment

Other: Physician Diagnosed: Not Tested

Individuals who self report that a medical professional has told them they likely have COVID-19 (and have since recovered), but did not get a confirmatory test.

Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace. The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech. We chose the Precision Bio test for 4 reasons It is available as a single use test kit in one sealed unit. It's a rapid test, with results available in 10 minutes. It has clear and easy to read instructions already included It has one of the lowest false positive rates of known tests at the moment

Other: Self-Diagnosed Not Tested

Participant suspects they contracted (and have since recovered) from COVID-19, but they do not have a medical diagnosis or confirmatory test.

Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace. The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech. We chose the Precision Bio test for 4 reasons It is available as a single use test kit in one sealed unit. It's a rapid test, with results available in 10 minutes. It has clear and easy to read instructions already included It has one of the lowest false positive rates of known tests at the moment

Other: Likely Exposed, No Symptoms. Not Tested

Participant suspects that they've been exposed to COVID-19, but have not shown symptoms and wonder if they have antibodies so they may return to some normalcy.

Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace. The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech. We chose the Precision Bio test for 4 reasons It is available as a single use test kit in one sealed unit. It's a rapid test, with results available in 10 minutes. It has clear and easy to read instructions already included It has one of the lowest false positive rates of known tests at the moment

Outcome Measures

Primary Outcome Measures

  1. Does Participant Accurately Read Result [Day 0]

    Comparison of participant reported self-test result vs physician review of self-test results via participant reported photograph of the test

  2. Acceptability and Usability of Tests [Day 0]

    Mesure of participant self report on ease of test administration via a custom survey assessment

Secondary Outcome Measures

  1. Social Distancing Behavior Change [Week 8]

    Change in Actual vs Anticipated social distancing behavior as measured by modified PROMIS Satisfaction with Social Questionnaire.

  2. COVID-19 Related Anxiety [Week 8]

    Change in economic, personal and other anxiety triggers as measured by a modified version of the Zung Self-Rating Anxiety Scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Reside and Currently in New York City

  • Does not have a blood clotting disease

  • Is not abnormally queasy about taking a blood sample

  • Not on any blood thinning medications

  • Able to consent

  • Willingness to take a blood sample

  • Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered

Contacts and Locations

Locations

Site City State Country Postal Code
1 ProofPilot Online App (https://p.proofpilot.com) New York New York United States 10003

Sponsors and Collaborators

  • ProofPilot
  • Radish Health
  • Sanesco

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ProofPilot
ClinicalTrials.gov Identifier:
NCT04393961
Other Study ID Numbers:
  • 2458
First Posted:
May 19, 2020
Last Update Posted:
May 19, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by ProofPilot
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2020